StoryFunding
Oxford Nanopore enters FTSE 250 index
Oxford Nanopore was included in the FTSE 250 index, recognizing its position as a major UK public company. The inclusion reflected the company's growth in sequencing adoption and commercial success.
More on Oxford Nanopore Technologies
- Oxford Nanopore announces improved chemistry targeting two human genomes per flow cellJan 2026
- Francis Van Parys appointed CEO, effective March 2, 20268 Dec 2025
- Oxford Nanopore announces PromethION Plus Flow Cell for ultra-high-output human genetics15 Oct 2025
- PromethION 2 Integrated launched in early access with integrated computing and software2024
- Oxford Nanopore Technologies lists on London Stock Exchange, raising £330MOct 2021